Anzeige
❌
Mehr »
Login
Sonntag, 22.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche

WKN: A1T87A | ISIN: US45408X3089 | Ticker-Symbol: IGS1
Tradegate
20.12.24
18:50 Uhr
0,330 Euro
-0,012
-3,51 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
IGC PHARMA INC Chart 1 Jahr
5-Tage-Chart
IGC PHARMA INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,3340,35021.12.
0,3320,35220.12.

Aktuelle News zur IGC PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrIGC Pharma, Inc.: IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025281ACCESSWIREPOTOMAC, MD / ACCESSWIRE / December 19, 2024 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced that the Company's management team will participate in BIO Partnering @ JPM...
► Artikel lesen
IGC PHARMA Aktie jetzt für 0€ handeln
02.12.IGC Pharma, Inc.: IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology170ACCESSWIRENew trials to evaluate IGC-AD1's potential impact on amyloid plaque, tau tangles, and cognitive decline in Alzheimer's diseaseExpanded research positions IGC-AD1 as a potential treatment targeting the...
► Artikel lesen
14.11.India Globalization Capital GAAP EPS of -$0.02 beats by $0.01, revenue of $0.41M beats by $0.21M3Seeking Alpha
14.11.IGC Pharma, Inc.: IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer's Pipeline192ACCESSWIREPOTOMAC, MD / ACCESSWIRE / November 14, 2024 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced its financial results and strategic advancements for the second fiscal quarter...
► Artikel lesen
06.11.IGC Pharma, Inc.: IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer's and Weight Loss Therapies184ACCESSWIREPOTOMAC, MD / ACCESSWIRE / November 6, 2024 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is pleased to announce the publication of a new interview with CEO Ram Mukunda, now...
► Artikel lesen
17.10.IGC Pharma, Inc.: IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1247ACCESSWIRE- Company Expands Phase 2 trial to Canada -POTOMAC, MD / ACCESSWIRE / October 17, 2024 / IGC Pharma, Inc (NYSE American:IGC) ("IGC" or the "Company"), today announced enrollment of patients at the Baycrest...
► Artikel lesen
03.10.IGC Pharma, Inc.: IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge209ACCESSWIREPOTOMAC, MD / ACCESSWIRE / October 3, 2024 / IGC Pharma, Inc. (NYSE American:IGC) proudly announces that it won 2 awards in the PREPARE Challenge (Pioneering Research for Early Prediction of Alzheimer's...
► Artikel lesen
27.09.IGC Pharma, Inc. - 8-K, Current Report11SEC Filings
04.09.InvestorNewsBreaks - IGC Pharma Inc. (NYSE American: IGC) Advances IGC-AD1 Research to Potentially Deliver 'Breakthrough Treatment' in Alzheimer's Disease1iNVEZZ.com
03.09.The Analyst Verdict: IGC Pharma In The Eyes Of 4 Experts1Benzinga.com
27.08.BioMedNewsBreaks - IGC Pharma Inc. (NYSE American: IGC) Announces Stockholders' Approval of All Disclosed Proposals at 2024 Annual Meeting1iNVEZZ.com
22.08.InvestorNewsBreaks - IGC Pharma Inc. (NYSE American: IGC) Releases Preclinical Research Evaluating New Molecule IGC-1C in Treatment of Alzheimer's Disease2iNVEZZ.com
09.08.IGC Pharma Revenue Declines 51% YoY Due To Completion Of Its Legacy Project In India, Highlights Important Milestones In Alzheimer's Research1Benzinga.com
09.08.India Globalization Capital GAAP EPS of -$0.03 in-line, revenue of $0.27M misses by $0.04M2Seeking Alpha
09.08.IGC Pharma Reports First Quarter Fiscal 2025 Results297Business WirePOTOMAC, Md.--(BUSINESS WIRE)--IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American: IGC) today announced its financial results for the first fiscal quarter of 2025 ended June 30, 2024. Q1...
► Artikel lesen
02.08.IGC Pharma, Inc. - 8-K, Current Report1SEC Filings
25.06.India Globalization Capital GAAP EPS of -$0.22 in-line, revenue of $1.35M beats by $0.11M4Seeking Alpha
25.06.IGC Pharma, Inc. Reports Financial Results for Fiscal Year Ended March 31, 2024159Business WirePOTOMAC, Md.--(BUSINESS WIRE)--IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American: IGC), a clinical-stage pharmaceutical company, has announced its financial results for the fiscal year ended...
► Artikel lesen
20.03.XFRA IGS1: WIEDERAUFNAHME/RESUMPTION316Xetra NewsboardFOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
20.03.IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer's Agitation179Business WirePOTOMAC, Md.--(BUSINESS WIRE)--IGC Pharma, Inc. ("IGC Pharma","IGC", or the"Company") (NYSE American: IGC) today announced the results of an interim analysis of its ongoing Phase 2 trial investigating...
► Artikel lesen
Seite:  1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1